- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GEOPHARMA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 32,000 | -4,71 % | Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 12-Month Low on Insider Selling | ||
| CSPC PHARMA | 0,620 | -2,18 % | M Stanley Cuts CSPC PHARMA TP to $6.6 w/ Lower EPS Forecasts | ||
| ACADIA PHARMACEUTICALS | 14,845 | -3,88 % | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | ||
| SELLAS LIFE SCIENCES | 1,132 | -3,41 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update | - Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapsed/Refractory... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 305,30 | +1,39 % | Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra | ||
| CATALYST PHARMACEUTICALS | 20,090 | +0,10 % | Vorstandsvorsitzender von Catalyst Pharmaceuticals verkauft Aktien im Wert von 3,1 Millionen US-Dollar | ||
| OPUS GENETICS | 0,949 | +2,48 % | Foundation Fighting Blindness: The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics | The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD)
RALEIGH, N.C., Oct. 25, 2024 /PRNewswire/ -- The RD Fund (Retinal... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,058 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse | Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,140 | -2,78 % | VIRX stock touches 52-week low at $0.15 amid market challenges | ||
| SAVARA | 2,800 | -6,04 % | Savara-Direktor Joseph McCracken erwirbt Stammaktien im Wert von 59.071 US-Dollar | ||
| GALECTIN THERAPEUTICS | 2,600 | -2,99 % | Galectin Therapeutics Inc.: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update | NAVIGATE trial on track for top-line results in December 2024 NORCROSS, Ga., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 4,810 | +30,35 % | Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic | CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical... ► Artikel lesen | |
| SCICLONE PHARMACEUTICALS | - | - | SCICLONE PHARMA (06600): (1) PROPOSAL FOR THE PRIVATISATION OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED BY SILVER PEGASUS INVESTMENT LIMITED BY WAY ... | ||
| NOVABAY PHARMACEUTICALS | 0,080 | 0,00 % | NovaBay calls for affirmative vote on asset sale and dissolution |
Das Unternehmen GEOPHARMA INC kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GEOPHARMA INC finden Sie auf Wallstreet Online.
